Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Subacute CNS demyelination after treatment with nivolumab for melanoma.
Validation of an Arabic version of Fatigue Severity Scale.
Fatigue in multiple sclerosis: The contribution of occult white matter damage.
Chronic constipation and co-morbidities: A prospective population-based nested case-control study.
Fingolimod for relapsing-remitting multiple sclerosis.
The role of aquaporin-4 antibodies in Chinese patients with neuromyelitis optica.
Melatonin Acts as Antioxidant and Improves Sleep in MS Patients.
How People with Multiple Sclerosis Rate Their Quality of Life: An EQ-5D Survey via the UK MS Register.
Plasmacytoid dendritic cells and autoimmune inflammation.
Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination.
Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI.
Assessment of upper extremity function in multiple sclerosis: review and opinion.
Management of fatigue in persons with multiple sclerosis.
Exclusive use of alternative medicine as a positive choice: a qualitative study of treatment assumptions among people with multiple sclerosis in denmark.
Elevated Cerebrospinal Fluid Opening Pressure in a Pediatric Demyelinating Disease Cohort.
Blood cells and endothelial barrier function.
Multiple sclerosis: Blood-based biomarkers provide insight into progressive MS.
Identification of cortical lesions using DIR and FLAIR in early stages of multiple sclerosis.
HLA associations in South Asian multiple sclerosis.
Injury to white matter tracts in relapsing-remitting multiple sclerosis: A possible therapeutic window within the first 5 years from onset using diffusion-tensor imaging tract-based spatial statistics.
Inhibition of Interferon regulatory factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS rebound.
Open Ring Sign Diagnostic of Multiple Sclerosis in the Emergency Department.
Progressive multifocal leukoencephalopathy: current treatment options and future perspectives.
The impact of persistence with therapy on inpatient admissions and emergency room visits in the US among patients with multiple sclerosis.
Pages
« first
‹ previous
…
412
413
414
415
416
417
418
419
420
…
next ›
last »